| dc.contributor | Departament de Salut |
| dc.date.accessioned | 2019-02-19T12:45:43Z |
| dc.date.available | 2019-02-19T12:45:43Z |
| dc.date.issued | 2018-06-12 |
| dc.identifier.citation | Apremilast: per al tractament de l'artritis psoriàsica activa en pacients adults que han tingut una resposta inadequada o han presentat intolerància a un fàrmac antireumàtic modificador de la malaltia. Barcelona: Servei Català de la Salut; 2018. |
| dc.identifier.uri | https://hdl.handle.net/11351/3793 |
| dc.description | Apremilast; Chronic inflammatory disease; Adult patients |
| dc.description.abstract | Psoriatic arthritis (APs) is a chronic inflammatory disease of the musculoskeletal system, usually seronegative (absence of rheumatoid factor in more than 85% of cases), associated with psoriasis. APs belongs to the group of rheumatic diseases called spondyloarthritis (or spondyloarthropathy) and has a wide variety of clinical manifestations. It can manifest itself with peripheral arthritis (virtually all patients), axial involvement, entesitis (inflammation in the area of insertion of tendons, facies and ligaments), dactilitis and affectation cutaneous and unguial. It may also present other extraarticular affections such as inflammatory bowel disease and ocular manifestations such as uveitis |
| dc.language.iso | cat |
| dc.publisher | Servei Català de la Salut |
| dc.relation.ispartof | Programa d'harmonització farmacoterapèutica, Servei Català de la Salut |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| dc.source | Scientia |
| dc.subject | Artritis psoriàsica - Tractament |
| dc.subject | Antireumàtics - Ús terapèutic |
| dc.subject | Medicaments - Assaigs clínics |
| dc.subject.mesh | Arthritis, Psoriatic |
| dc.subject.mesh | /drug therapy |
| dc.subject.mesh | Drug Evaluation |
| dc.title | Apremilast: per al tractament de l'artritis psoriàsica activa en pacients adults que han tingut una resposta inadequada o han presentat intolerància a un fàrmac antireumàtic modificador de la malaltia |
| dc.type | info:eu-repo/semantics/report |
| dc.subject.decs | artritis psoriásica |
| dc.subject.decs | /tratamiento farmacológico |
| dc.subject.decs | evaluación de medicamentos |
| dc.type.version | info:eu-repo/semantics/publishedVersion |
| dc.audience | Professionals |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess |